10/16/20 15:51 | 10/14/20 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martin John C | CA | D | | P.d | 1,440 | 19.00 | 0 | 76 | 4 | 1,952 | I | | | | | | | | | | | | | | |
12/4/18 20:02 | 12/3/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 2,878 | D | | | | | | | | | | | | | | |
12/4/18 20:02 | 12/3/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,560 | 71.20 | 0 | -50 | -2 | 2,878 | D | | | | | | | | | | | | | | |
11/5/18 19:45 | 11/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
11/5/18 19:45 | 11/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,478 | 69.55 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
10/3/18 17:45 | 10/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
10/3/18 17:45 | 10/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,902 | 78.04 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
9/6/18 17:24 | 9/4/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
9/6/18 17:24 | 9/4/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,708 | 74.16 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
8/3/18 16:41 | 8/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
8/3/18 16:41 | 8/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,893 | 77.85 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
7/5/18 20:00 | 7/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
7/5/18 20:00 | 7/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,540 | 70.81 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
6/5/18 19:34 | 6/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
6/5/18 19:34 | 6/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,406 | 68.13 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
5/3/18 13:07 | 5/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
5/3/18 13:07 | 5/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,610 | 72.19 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
4/4/18 19:34 | 4/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
4/4/18 19:34 | 4/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | D | | S.d | -3,657 | 73.14 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
3/5/18 18:54 | 3/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 3,018 | D | | | | | | | | | | | | | | |
3/5/18 18:54 | 3/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -3,932 | 78.65 | 0 | -50 | -2 | 3,018 | D | | | | | | | | | | | | | | |
2/5/18 20:38 | 2/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 2,997 | D | | | | | | | | | | | | | | |
2/5/18 20:38 | 2/1/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -4,178 | 83.56 | 0 | -50 | -2 | 2,997 | D | | | | | | | | | | | | | | |
1/4/18 19:54 | 1/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,180 | 23.60 | 0 | 50 | 2 | 2,997 | D | | | | | | | | | | | | | | |
1/4/18 19:54 | 1/2/18 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -3,681 | 73.62 | 0 | -50 | -2 | 2,997 | D | | | | | | | | | | | | | | |
12/5/17 19:49 | 12/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 3 | 2,997 | D | | | | | | | | | | | | | | |
12/5/17 19:49 | 12/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,498 | 74.98 | 0 | -73 | -2 | 2,997 | D | | | | | | | | | | | | | | |
11/3/17 19:04 | 11/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 3 | 2,997 | D | | | | | | | | | | | | | | |
11/3/17 19:04 | 11/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,510 | 75.13 | 0 | -73 | -2 | 2,997 | D | | | | | | | | | | | | | | |
10/4/17 19:19 | 10/2/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 3 | 2,997 | D | | | | | | | | | | | | | | |
10/4/17 19:19 | 10/2/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -6,054 | 82.56 | 0 | -73 | -2 | 2,997 | D | | | | | | | | | | | | | | |
9/6/17 20:23 | 9/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 3 | 2,997 | D | | | | | | | | | | | | | | |
9/6/17 20:23 | 9/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -6,095 | 83.11 | 0 | -73 | -2 | 2,997 | D | | | | | | | | | | | | | | |
8/3/17 18:55 | 8/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 2 | 3,127 | D | | | | | | | | | | | | | | |
8/3/17 18:55 | 8/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,563 | 75.86 | 0 | -73 | -2 | 3,127 | D | | | | | | | | | | | | | | |
7/6/17 18:38 | 7/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 2 | 3,127 | D | | | | | | | | | | | | | | |
7/6/17 18:38 | 7/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,207 | 71.00 | 0 | -73 | -2 | 3,127 | D | | | | | | | | | | | | | | |
6/5/17 18:26 | 6/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 0 | 73 | 2 | 3,200 | D | | | | | | | | | | | | | | |
6/5/17 18:26 | 6/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -4,785 | 65.24 | 0 | -73 | -2 | 3,200 | D | | | | | | | | | | | | | | |
5/3/17 17:42 | 5/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 33 | 73 | 2 | 3,127 | D | -32 | -21 | -6 | -5 | 1 | 4 | 4 | 0 | 1 | 1 | | | | |
5/3/17 17:42 | 5/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,009 | 68.31 | 33 | -73 | -2 | 3,127 | D | -32 | -21 | -6 | -5 | 1 | 4 | 4 | 0 | 1 | 1 | | | | |
4/5/17 17:29 | 4/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 33 | 73 | 2 | 3,127 | D | -29 | -28 | -13 | -9 | -2 | -2 | -1 | -1 | 0 | -1 | 2 | | | |
4/5/17 17:29 | 4/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -4,926 | 67.18 | 33 | -73 | -2 | 3,127 | D | -29 | -28 | -13 | -9 | -2 | -2 | -1 | -1 | 0 | -1 | 2 | | | |
3/3/17 18:29 | 3/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 33 | 73 | 2 | 3,127 | D | -29 | -19 | -8 | -5 | -1 | 8 | 2 | 0 | -1 | -3 | -3 | | | |
3/3/17 18:29 | 3/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,161 | 70.38 | 33 | -73 | -2 | 3,127 | D | -29 | -19 | -8 | -5 | -1 | 8 | 2 | 0 | -1 | -3 | -3 | | | |
2/3/17 17:25 | 2/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 33 | 73 | 2 | 3,131 | D | -30 | -14 | -9 | -2 | -2 | -2 | 3 | 1 | 0 | -9 | -3 | -5 | | |
2/3/17 17:25 | 2/1/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,322 | 72.57 | 33 | -73 | -2 | 3,131 | D | -30 | -14 | -9 | -2 | -2 | -2 | 3 | 1 | 0 | -9 | -3 | -5 | | |
1/5/17 15:39 | 1/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,582 | 21.58 | 33 | 73 | 2 | 3,131 | D | -18 | -21 | -10 | 0 | 3 | 2 | 4 | 6 | 0 | -3 | -5 | -12 | | |
1/5/17 15:39 | 1/3/17 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -5,397 | 73.59 | 33 | -73 | -2 | 3,131 | D | -18 | -21 | -10 | 0 | 3 | 2 | 4 | 6 | 0 | -3 | -5 | -12 | | |
12/5/16 12:54 | 12/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,131 | D | -26 | -27 | -16 | -5 | -3 | -5 | -3 | -3 | 0 | 0 | 6 | -4 | | |
12/5/16 12:54 | 12/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -7,333 | 73.33 | 33 | -100 | -3 | 3,131 | D | -26 | -27 | -16 | -5 | -3 | -5 | -3 | -3 | 0 | 0 | 6 | -4 | | |
11/3/16 18:10 | 11/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,131 | D | -32 | -32 | -15 | -9 | -11 | -1 | -2 | -2 | 1 | 9 | 1 | 1 | -4 | |
11/3/16 18:10 | 11/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -7,376 | 73.76 | 33 | -100 | -3 | 3,131 | D | -32 | -32 | -15 | -9 | -11 | -1 | -2 | -2 | 1 | 9 | 1 | 1 | -4 | |
10/5/16 12:52 | 10/3/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,131 | D | -25 | -21 | -20 | -9 | -5 | 0 | -5 | -1 | 0 | -4 | -6 | 0 | -13 | |
10/5/16 12:52 | 10/3/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -7,763 | 77.63 | 33 | -100 | -3 | 3,131 | D | -25 | -21 | -20 | -9 | -5 | 0 | -5 | -1 | 0 | -4 | -6 | 0 | -13 | |
9/6/16 14:40 | 9/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,863 | M | -26 | -23 | -13 | -12 | -13 | -3 | -4 | -1 | 1 | 3 | 1 | -5 | -9 | |
9/6/16 14:40 | 9/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -7,748 | 77.48 | 33 | -100 | -3 | 3,863 | M | -26 | -23 | -13 | -12 | -13 | -3 | -4 | -1 | 1 | 3 | 1 | -5 | -9 | |
8/3/16 16:51 | 8/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | -11 | -32 | -3 | -8 | -3 | -7 | -8 | -2 | 0 | -1 | -2 | -8 | -8 | |
8/3/16 16:51 | 8/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -8,050 | 80.50 | 33 | -100 | -2 | 4,020 | D | -11 | -32 | -3 | -8 | -3 | -7 | -8 | -2 | 0 | -1 | -2 | -8 | -8 | |
7/6/16 13:28 | 7/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | -2 | -26 | -14 | -12 | 1 | 0 | 1 | 2 | 2 | 3 | -5 | -6 | -10 | |
7/6/16 13:28 | 7/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -8,473 | 84.73 | 33 | -100 | -2 | 4,020 | D | -2 | -26 | -14 | -12 | 1 | 0 | 1 | 2 | 2 | 3 | -5 | -6 | -10 | |
6/3/16 16:51 | 6/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | 7 | -23 | -17 | -1 | -15 | 5 | 4 | 1 | 2 | 0 | -1 | -8 | -13 | |
6/3/16 16:51 | 6/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -8,672 | 86.72 | 33 | -100 | -2 | 4,020 | D | 7 | -23 | -17 | -1 | -15 | 5 | 4 | 1 | 2 | 0 | -1 | -8 | -13 | |
5/4/16 14:44 | 5/2/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | 14 | -16 | -19 | 6 | -7 | -10 | -14 | -10 | -2 | -1 | -1 | -8 | -15 | |
5/4/16 14:44 | 5/2/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -8,782 | 87.82 | 33 | -100 | -2 | 4,020 | D | 14 | -16 | -19 | 6 | -7 | -10 | -14 | -10 | -2 | -1 | -1 | -8 | -15 | |
4/5/16 19:49 | 4/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | 30 | -3 | -3 | -6 | 6 | 4 | 5 | 2 | 2 | 0 | -9 | -11 | -16 | -28 |
4/5/16 19:49 | 4/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | Exec CB | S.d | -9,324 | 93.24 | 33 | -100 | -2 | 4,020 | D | 30 | -3 | -3 | -6 | 6 | 4 | 5 | 2 | 2 | 0 | -9 | -11 | -16 | -28 |
3/3/16 14:47 | 3/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 4,020 | D | 10 | -13 | -15 | -16 | -2 | 1 | 0 | 1 | -1 | -1 | 7 | -2 | -11 | -19 |
3/3/16 14:47 | 3/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -8,858 | 88.58 | 33 | -100 | -2 | 4,020 | D | 10 | -13 | -15 | -16 | -2 | 1 | 0 | 1 | -1 | -1 | 7 | -2 | -11 | -19 |
2/3/16 17:43 | 2/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,948 | D | 4 | -21 | -30 | -23 | -19 | -15 | -10 | -6 | 0 | 1 | 2 | 1 | -7 | -14 |
2/3/16 17:43 | 2/1/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -8,342 | 83.42 | 33 | -100 | -2 | 3,948 | D | 4 | -21 | -30 | -23 | -19 | -15 | -10 | -6 | 0 | 1 | 2 | 1 | -7 | -14 |
1/6/16 17:21 | 1/4/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,640 | 16.40 | 33 | 100 | 3 | 3,948 | D | 35 | 4 | -13 | 0 | -6 | -1 | -4 | -3 | -4 | -3 | -14 | -2 | -14 | -22 |
1/6/16 17:21 | 1/4/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -9,768 | 97.68 | 33 | -100 | -2 | 3,948 | D | 35 | 4 | -13 | 0 | -6 | -1 | -4 | -3 | -4 | -3 | -14 | -2 | -14 | -22 |
12/3/15 13:57 | 12/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 3,948 | D | 41 | 3 | -8 | 1 | 3 | -3 | -2 | -3 | -3 | -2 | -6 | -16 | -17 | -29 |
12/3/15 13:57 | 12/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,873 | 105.82 | 33 | -150 | -4 | 3,948 | D | 41 | 3 | -8 | 1 | 3 | -3 | -2 | -3 | -3 | -2 | -6 | -16 | -17 | -29 |
11/4/15 13:23 | 11/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 3,948 | D | 55 | 0 | 7 | -8 | 3 | 11 | 1 | 0 | 0 | 0 | -7 | -20 | -21 | -32 |
11/4/15 13:23 | 11/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -16,413 | 109.42 | 33 | -150 | -4 | 3,948 | D | 55 | 0 | 7 | -8 | 3 | 11 | 1 | 0 | 0 | 0 | -7 | -20 | -21 | -32 |
10/5/15 13:28 | 10/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 3,948 | D | 59 | -5 | 1 | -15 | -6 | -10 | -7 | 2 | 1 | 2 | 12 | 0 | -2 | -19 |
10/5/15 13:28 | 10/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,622 | 97.48 | 33 | -150 | -4 | 3,948 | D | 59 | -5 | 1 | -15 | -6 | -10 | -7 | 2 | 1 | 2 | 12 | 0 | -2 | -19 |
9/3/15 15:06 | 9/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 3,948 | D | 72 | -4 | 1 | -8 | -11 | -9 | 4 | -3 | -2 | 3 | -5 | 1 | -16 | -24 |
9/3/15 15:06 | 9/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,410 | 102.73 | 33 | -150 | -4 | 3,948 | D | 72 | -4 | 1 | -8 | -11 | -9 | 4 | -3 | -2 | 3 | -5 | 1 | -16 | -24 |
8/26/15 17:51 | 8/25/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S | -14,010 | 105.17 | 33 | -133 | -3 | 3,948 | M | 73 | -4 | -1 | -8 | -13 | -14 | -11 | -9 | 1 | -5 | -4 | 0 | -16 | -24 |
8/4/15 17:07 | 8/3/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,214 | D | 94 | 31 | 13 | 14 | -2 | 2 | 2 | 3 | 0 | -2 | -15 | -9 | -30 | -32 |
8/4/15 17:07 | 8/3/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,877 | 119.18 | 33 | -150 | -3 | 4,214 | D | 94 | 31 | 13 | 14 | -2 | 2 | 2 | 3 | 0 | -2 | -15 | -9 | -30 | -32 |
7/6/15 16:02 | 7/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,214 | D | 121 | 33 | 22 | 17 | 4 | -2 | -6 | 0 | 0 | -2 | 3 | -15 | -12 | -25 |
7/6/15 16:02 | 7/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,470 | 116.46 | 33 | -150 | -3 | 4,214 | D | 121 | 33 | 22 | 17 | 4 | -2 | -6 | 0 | 0 | -2 | 3 | -15 | -12 | -25 |
6/3/15 18:07 | 6/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,256 | D | 109 | 40 | 14 | 11 | 8 | 8 | 2 | 1 | -1 | 0 | 2 | -8 | -7 | -23 |
6/3/15 18:07 | 6/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,092 | 113.95 | 33 | -150 | -3 | 4,256 | D | 109 | 40 | 14 | 11 | 8 | 8 | 2 | 1 | -1 | 0 | 2 | -8 | -7 | -23 |
5/5/15 17:47 | 5/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,256 | D | 102 | 36 | -7 | 0 | 5 | 3 | 0 | 3 | -1 | 2 | 11 | 16 | 6 | -14 |
5/5/15 17:47 | 5/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,742 | 104.95 | 33 | -150 | -3 | 4,256 | D | 102 | 36 | -7 | 0 | 5 | 3 | 0 | 3 | -1 | 2 | 11 | 16 | 6 | -14 |
4/3/15 17:24 | 4/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,256 | D | 107 | 33 | -7 | 4 | -4 | -1 | -3 | -2 | 1 | 4 | 8 | 18 | 1 | -2 |
4/3/15 17:24 | 4/1/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,511 | 96.74 | 33 | -150 | -3 | 4,256 | D | 107 | 33 | -7 | 4 | -4 | -1 | -3 | -2 | 1 | 4 | 8 | 18 | 1 | -2 |
3/4/15 19:48 | 3/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,256 | D | 137 | 26 | -4 | 2 | -1 | 5 | 0 | -1 | 0 | -4 | -5 | 11 | 2 | -13 |
3/4/15 19:48 | 3/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,526 | 103.51 | 33 | -150 | -3 | 4,256 | D | 137 | 26 | -4 | 2 | -1 | 5 | 0 | -1 | 0 | -4 | -5 | 11 | 2 | -13 |
2/4/15 20:15 | 2/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,123 | D | 164 | 36 | 16 | -4 | -1 | 10 | 2 | 3 | 2 | 0 | 5 | 4 | 20 | -10 |
2/4/15 20:15 | 2/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,815 | 105.44 | 33 | -150 | -4 | 4,123 | D | 164 | 36 | 16 | -4 | -1 | 10 | 2 | 3 | 2 | 0 | 5 | 4 | 20 | -10 |
1/6/15 16:20 | 1/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,175 | 14.50 | 33 | 150 | 4 | 4,123 | D | 158 | 30 | 11 | -9 | -4 | -7 | 8 | 2 | 2 | 4 | 1 | 1 | 18 | 3 |
1/6/15 16:20 | 1/2/15 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.dm | -14,267 | 95.12 | 33 | -150 | -4 | 4,123 | D | 158 | 30 | 11 | -9 | -4 | -7 | 8 | 2 | 2 | 4 | 1 | 1 | 18 | 3 |
12/3/14 19:13 | 12/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 4 | 4,123 | D | 173 | 37 | 23 | -7 | -4 | -5 | 2 | 2 | 1 | 5 | -6 | 2 | 13 | 4 |
12/3/14 19:13 | 12/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,165 | 100.72 | 33 | -141 | -3 | 4,123 | D | 173 | 37 | 23 | -7 | -4 | -5 | 2 | 2 | 1 | 5 | -6 | 2 | 13 | 4 |
11/5/14 14:05 | 11/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 227 | 58 | 39 | 18 | 1 | 14 | -1 | -4 | -3 | -2 | -7 | -9 | -7 | 0 |
11/5/14 14:05 | 11/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,525 | 110.40 | 33 | -141 | -3 | 4,429 | D | 227 | 58 | 39 | 18 | 1 | 14 | -1 | -4 | -3 | -2 | -7 | -9 | -7 | 0 |
10/3/14 14:57 | 10/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 215 | 68 | 41 | 19 | 2 | 1 | -1 | -3 | 2 | 1 | 7 | -9 | -6 | -5 |
10/3/14 14:57 | 10/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,894 | 105.91 | 33 | -141 | -3 | 4,429 | D | 215 | 68 | 41 | 19 | 2 | 1 | -1 | -3 | 2 | 1 | 7 | -9 | -6 | -5 |
9/4/14 17:09 | 9/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 279 | 80 | 32 | 32 | 21 | 16 | 5 | 2 | -1 | 1 | -2 | -4 | -3 | -2 |
9/4/14 17:09 | 9/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -15,278 | 108.64 | 33 | -141 | -3 | 4,429 | D | 279 | 80 | 32 | 32 | 21 | 16 | 5 | 2 | -1 | 1 | -2 | -4 | -3 | -2 |
8/4/14 18:16 | 8/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 229 | 48 | 13 | 18 | 13 | 2 | 1 | -2 | 0 | 0 | 19 | 24 | 15 | 30 |
8/4/14 18:16 | 8/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -12,872 | 91.53 | 33 | -141 | -3 | 4,429 | D | 229 | 48 | 13 | 18 | 13 | 2 | 1 | -2 | 0 | 0 | 19 | 24 | 15 | 30 |
7/3/14 14:28 | 7/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 248 | 67 | 16 | 18 | 6 | 8 | 8 | 5 | 1 | 2 | 5 | 21 | 8 | 33 |
7/3/14 14:28 | 7/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,930 | 84.84 | 33 | -141 | -3 | 4,429 | D | 248 | 67 | 16 | 18 | 6 | 8 | 8 | 5 | 1 | 2 | 5 | 21 | 8 | 33 |
6/4/14 14:48 | 6/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 227 | 55 | 10 | 0 | 13 | 3 | 0 | 1 | 1 | -4 | 6 | 32 | 22 | 39 |
6/4/14 14:48 | 6/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,436 | 81.32 | 33 | -141 | -3 | 4,429 | D | 227 | 55 | 10 | 0 | 13 | 3 | 0 | 1 | 1 | -4 | 6 | 32 | 22 | 39 |
5/5/14 17:52 | 5/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 199 | 49 | 7 | -4 | 8 | 18 | 5 | 2 | -2 | 0 | 3 | 15 | 44 | 33 |
5/5/14 17:52 | 5/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,112 | 79.02 | 33 | -141 | -3 | 4,429 | D | 199 | 49 | 7 | -4 | 8 | 18 | 5 | 2 | -2 | 0 | 3 | 15 | 44 | 33 |
4/3/14 15:20 | 4/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,429 | D | 210 | 55 | 18 | -2 | -11 | -5 | 3 | 8 | 0 | -4 | 5 | 18 | 43 | 33 |
4/3/14 15:20 | 4/1/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -10,302 | 73.26 | 33 | -141 | -3 | 4,429 | D | 210 | 55 | 18 | -2 | -11 | -5 | 3 | 8 | 0 | -4 | 5 | 18 | 43 | 33 |
3/5/14 14:51 | 3/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,257 | D | 264 | 89 | 38 | 11 | 2 | 1 | 0 | -1 | 0 | -4 | -11 | 0 | 32 | 24 |
3/5/14 14:51 | 3/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,495 | 81.74 | 33 | -141 | -3 | 4,257 | D | 264 | 89 | 38 | 11 | 2 | 1 | 0 | -1 | 0 | -4 | -11 | 0 | 32 | 24 |
2/5/14 18:53 | 2/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 3 | 4,256 | D | 234 | 107 | 35 | 16 | 10 | 9 | 2 | 1 | -2 | 4 | 2 | 0 | 17 | 25 |
2/5/14 18:53 | 2/3/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,244 | 79.96 | 33 | -141 | -3 | 4,256 | D | 234 | 107 | 35 | 16 | 10 | 9 | 2 | 1 | -2 | 4 | 2 | 0 | 17 | 25 |
1/6/14 17:38 | 1/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,126 | 8.01 | 33 | 141 | 4 | 4,057 | D | 263 | 98 | 39 | 20 | 5 | 6 | -1 | -1 | -1 | 2 | 12 | -1 | 19 | 32 |
1/6/14 17:38 | 1/2/14 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -10,550 | 75.02 | 33 | -141 | -3 | 4,057 | D | 263 | 98 | 39 | 20 | 5 | 6 | -1 | -1 | -1 | 2 | 12 | -1 | 19 | 32 |
12/4/13 15:55 | 12/2/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 263 | 94 | 44 | 19 | 6 | 7 | 1 | -3 | 0 | 1 | 3 | 10 | 14 | 39 |
12/4/13 15:55 | 12/2/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -20,961 | 74.27 | 33 | -282 | -7 | 4,057 | D | 263 | 94 | 44 | 19 | 6 | 7 | 1 | -3 | 0 | 1 | 3 | 10 | 14 | 39 |
11/5/13 20:14 | 11/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 238 | 107 | 31 | 16 | 11 | 9 | -1 | -5 | -3 | -3 | 4 | 12 | 13 | 58 |
11/5/13 20:14 | 11/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -19,990 | 70.83 | 33 | -282 | -7 | 4,057 | D | 238 | 107 | 31 | 16 | 11 | 9 | -1 | -5 | -3 | -3 | 4 | 12 | 13 | 58 |
10/3/13 16:10 | 10/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 218 | 88 | 31 | 20 | 6 | -1 | 0 | -2 | 2 | -5 | 15 | 22 | 20 | 69 |
10/3/13 16:10 | 10/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,697 | 62.70 | 33 | -282 | -7 | 4,057 | D | 218 | 88 | 31 | 20 | 6 | -1 | 0 | -2 | 2 | -5 | 15 | 22 | 20 | 69 |
9/5/13 19:44 | 9/3/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 206 | 113 | 35 | 22 | 2 | 5 | 2 | 0 | 0 | 3 | 1 | 19 | 31 | 75 |
9/5/13 19:44 | 9/3/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,209 | 60.97 | 33 | -282 | -7 | 4,057 | D | 206 | 113 | 35 | 22 | 2 | 5 | 2 | 0 | 0 | 3 | 1 | 19 | 31 | 75 |
8/5/13 16:08 | 8/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 197 | 127 | 52 | 12 | 26 | 7 | 3 | 0 | -2 | -3 | 0 | 17 | 29 | 51 |
8/5/13 16:08 | 8/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -17,390 | 61.61 | 33 | -282 | -7 | 4,057 | D | 197 | 127 | 52 | 12 | 26 | 7 | 3 | 0 | -2 | -3 | 0 | 17 | 29 | 51 |
7/3/13 17:38 | 7/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 152 | 109 | 42 | 10 | -8 | 2 | 7 | 2 | 3 | 6 | 19 | 21 | 44 | 67 |
7/3/13 17:38 | 7/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,678 | 52.00 | 33 | -282 | -7 | 4,057 | D | 152 | 109 | 42 | 10 | -8 | 2 | 7 | 2 | 3 | 6 | 19 | 21 | 44 | 67 |
6/5/13 18:36 | 6/3/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 153 | 109 | 40 | 16 | -2 | -7 | -6 | -6 | 2 | 4 | 4 | 21 | 47 | 63 |
6/5/13 18:36 | 6/3/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,913 | 52.84 | 33 | -282 | -7 | 4,057 | D | 153 | 109 | 40 | 16 | -2 | -7 | -6 | -6 | 2 | 4 | 4 | 21 | 47 | 63 |
5/3/13 18:15 | 5/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 169 | 101 | 56 | 32 | 17 | 0 | -2 | 2 | -1 | -4 | -4 | 13 | 34 | 43 |
5/3/13 18:15 | 5/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -14,161 | 50.17 | 33 | -282 | -7 | 4,057 | D | 169 | 101 | 56 | 32 | 17 | 0 | -2 | 2 | -1 | -4 | -4 | 13 | 34 | 43 |
4/3/13 16:26 | 4/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 7 | 4,057 | D | 129 | 103 | 46 | 33 | 14 | 4 | 8 | 1 | 0 | 1 | 5 | 8 | 32 | 54 |
4/3/13 16:26 | 4/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -13,634 | 48.30 | 33 | -282 | -7 | 4,057 | D | 129 | 103 | 46 | 33 | 14 | 4 | 8 | 1 | 0 | 1 | 5 | 8 | 32 | 54 |
3/5/13 17:13 | 3/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 8 | 4,006 | D | 128 | 93 | 52 | 17 | 12 | 9 | 6 | 2 | 1 | 2 | 6 | 18 | 35 | 86 |
3/5/13 17:13 | 3/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -12,176 | 43.14 | 33 | -282 | -7 | 4,006 | D | 128 | 93 | 52 | 17 | 12 | 9 | 6 | 2 | 1 | 2 | 6 | 18 | 35 | 86 |
2/5/13 16:47 | 2/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 7.63 | 33 | 282 | 8 | 4,005 | D | 106 | 61 | 48 | 17 | 7 | 2 | 1 | -1 | -2 | 0 | 12 | 35 | 52 | 105 |
2/5/13 16:47 | 2/1/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -11,410 | 40.43 | 33 | -282 | -7 | 4,005 | D | 106 | 61 | 48 | 17 | 7 | 2 | 1 | -1 | -2 | 0 | 12 | 35 | 52 | 105 |
1/4/13 15:49 | 1/2/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 2,154 | 15.27 | 33 | 141 | 8 | 2,003 | D | 107 | 83 | 45 | 11 | -1 | -2 | 3 | 4 | 1 | 4 | 6 | 26 | 42 | 98 |
1/4/13 15:49 | 1/2/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -10,508 | 74.46 | 33 | -141 | -7 | 2,003 | D | 107 | 83 | 45 | 11 | -1 | -2 | 3 | 4 | 1 | 4 | 6 | 26 | 42 | 98 |
12/12/12 15:09 | 12/10/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 200 | 15.63 | 33 | 13 | 1 | 2,003 | D | 106 | 97 | 54 | 28 | 14 | 1 | 2 | 3 | 0 | -1 | 2 | 20 | 36 | 85 |
12/5/12 18:30 | 12/3/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 146 | 8 | 1,990 | D | 97 | 87 | 51 | 29 | 11 | 2 | -3 | -2 | -1 | 2 | 2 | 21 | 38 | 95 |
12/5/12 18:30 | 12/3/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -10,915 | 75.01 | 33 | -146 | -7 | 1,990 | D | 97 | 87 | 51 | 29 | 11 | 2 | -3 | -2 | -1 | 2 | 2 | 21 | 38 | 95 |
11/5/12 18:22 | 11/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,990 | D | 66 | 63 | 30 | 17 | 0 | -1 | 1 | 0 | 1 | -3 | 11 | 21 | 59 | 107 |
11/5/12 18:22 | 11/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -9,848 | 67.70 | 33 | -145 | -7 | 1,990 | D | 66 | 63 | 30 | 17 | 0 | -1 | 1 | 0 | 1 | -3 | 11 | 21 | 59 | 107 |
10/3/12 12:46 | 10/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,990 | D | 96 | 83 | 44 | 33 | 22 | 16 | 2 | 4 | 1 | -1 | -3 | 9 | 36 | 82 |
10/3/12 12:46 | 10/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -9,823 | 67.53 | 33 | -145 | -7 | 1,990 | D | 96 | 83 | 44 | 33 | 22 | 16 | 2 | 4 | 1 | -1 | -3 | 9 | 36 | 82 |
9/6/12 20:33 | 9/4/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,990 | D | 76 | 51 | 28 | 19 | 14 | 1 | 2 | 2 | 0 | 0 | 17 | 25 | 55 | 113 |
9/6/12 20:33 | 9/4/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -8,390 | 57.68 | 33 | -145 | -7 | 1,990 | D | 76 | 51 | 28 | 19 | 14 | 1 | 2 | 2 | 0 | 0 | 17 | 25 | 55 | 113 |
8/3/12 16:52 | 8/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,990 | D | 63 | 44 | 16 | 11 | 15 | 12 | 12 | 3 | 1 | 0 | 1 | 18 | 42 | 110 |
8/3/12 16:52 | 8/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -7,854 | 54.00 | 33 | -145 | -7 | 1,990 | D | 63 | 44 | 16 | 11 | 15 | 12 | 12 | 3 | 1 | 0 | 1 | 18 | 42 | 110 |
7/3/12 18:07 | 7/2/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,990 | D | 48 | 23 | 26 | 6 | 1 | 4 | 3 | 1 | -1 | -1 | 3 | 30 | 44 | 106 |
7/3/12 18:07 | 7/2/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -7,465 | 51.32 | 33 | -145 | -7 | 1,990 | D | 48 | 23 | 26 | 6 | 1 | 4 | 3 | 1 | -1 | -1 | 3 | 30 | 44 | 106 |
6/5/12 12:36 | 6/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,989 | D | 42 | 20 | 24 | 6 | -4 | -6 | -2 | -3 | -1 | 1 | 6 | 17 | 51 | 109 |
6/5/12 12:36 | 6/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -7,091 | 48.76 | 33 | -145 | -7 | 1,989 | D | 42 | 20 | 24 | 6 | -4 | -6 | -2 | -3 | -1 | 1 | 6 | 17 | 51 | 109 |
5/3/12 15:05 | 5/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,989 | D | 35 | 25 | 25 | 6 | 12 | 13 | 1 | -1 | -1 | -2 | -6 | 3 | 30 | 110 |
5/3/12 15:05 | 5/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -7,521 | 51.71 | 33 | -145 | -7 | 1,989 | D | 35 | 25 | 25 | 6 | 12 | 13 | 1 | -1 | -1 | -2 | -6 | 3 | 30 | 110 |
4/4/12 18:18 | 4/2/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,989 | D | 6 | 12 | 27 | 15 | 8 | 3 | 3 | 1 | 1 | -4 | 9 | 10 | 46 | 98 |
4/4/12 18:18 | 4/2/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -7,037 | 48.38 | 33 | -145 | -7 | 1,989 | D | 6 | 12 | 27 | 15 | 8 | 3 | 3 | 1 | 1 | -4 | 9 | 10 | 46 | 98 |
3/5/12 20:33 | 3/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,949 | D | 0 | 18 | 18 | 18 | -1 | -13 | 6 | 2 | -1 | 0 | 5 | 5 | 24 | 95 |
3/5/12 20:33 | 3/1/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -6,724 | 46.23 | 33 | -145 | -7 | 1,949 | D | 0 | 18 | 18 | 18 | -1 | -13 | 6 | 2 | -1 | 0 | 5 | 5 | 24 | 95 |
2/9/12 19:07 | 2/7/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 1,301 | 8.94 | 33 | 145 | 8 | 1,949 | D | 17 | 40 | 42 | 32 | 36 | 15 | 12 | -1 | 0 | 2 | -14 | -6 | 6 | 50 |
2/9/12 19:07 | 2/7/12 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -8,014 | 55.09 | 33 | -145 | -7 | 1,949 | D | 17 | 40 | 42 | 32 | 36 | 15 | 12 | -1 | 0 | 2 | -14 | -6 | 6 | 50 |
12/7/11 17:50 | 12/5/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 381 | 8.22 | 33 | 46 | 2 | 1,949 | D | -15 | 7 | -3 | 0 | -3 | -2 | 1 | 0 | -2 | -2 | 8 | 18 | 24 | 87 |
12/7/11 17:50 | 12/5/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -1,852 | 40.00 | 33 | -46 | -2 | 1,949 | D | -15 | 7 | -3 | 0 | -3 | -2 | 1 | 0 | -2 | -2 | 8 | 18 | 24 | 87 |
12/5/11 20:14 | 12/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.dm | 378 | 8.22 | 33 | 46 | 2 | 1,949 | D | -15 | 6 | -4 | 1 | -5 | -4 | 2 | 0 | -1 | -3 | 5 | 15 | 21 | 87 |
12/5/11 20:14 | 12/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.dm | -1,841 | 40.01 | 33 | -46 | -2 | 1,949 | D | -15 | 6 | -4 | 1 | -5 | -4 | 2 | 0 | -1 | -3 | 5 | 15 | 21 | 87 |
11/3/11 17:17 | 11/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,949 | D | -6 | 3 | 1 | 10 | 7 | 1 | -2 | -4 | -1 | -3 | -4 | 34 | 23 | 64 |
11/3/11 17:17 | 11/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,790 | 41.05 | 33 | -92 | -5 | 1,949 | D | -6 | 3 | 1 | 10 | 7 | 1 | -2 | -4 | -1 | -3 | -4 | 34 | 23 | 64 |
10/12/11 17:06 | 10/10/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,949 | D | -12 | 10 | -4 | -5 | -1 | 0 | 2 | 0 | 1 | 1 | -1 | 10 | 14 | 69 |
10/12/11 17:06 | 10/10/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,693 | 40.00 | 33 | -92 | -5 | 1,949 | D | -12 | 10 | -4 | -5 | -1 | 0 | 2 | 0 | 1 | 1 | -1 | 10 | 14 | 69 |
9/6/11 21:13 | 9/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,949 | D | -15 | 14 | -5 | -5 | -9 | 4 | 2 | -3 | 3 | -2 | -2 | 2 | 19 | 50 |
9/6/11 21:13 | 9/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,699 | 40.07 | 33 | -92 | -5 | 1,949 | D | -15 | 14 | -5 | -5 | -9 | 4 | 2 | -3 | 3 | -2 | -2 | 2 | 19 | 50 |
8/3/11 17:59 | 8/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,949 | D | -18 | 17 | 5 | -3 | 1 | -3 | -6 | -6 | -6 | -4 | 0 | 5 | 23 | 34 |
8/3/11 17:59 | 8/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,851 | 41.72 | 33 | -92 | -5 | 1,949 | D | -18 | 17 | 5 | -3 | 1 | -3 | -6 | -6 | -6 | -4 | 0 | 5 | 23 | 34 |
7/6/11 18:47 | 7/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,949 | D | -9 | 20 | 14 | -3 | 3 | 5 | 4 | 0 | 1 | -2 | -6 | -11 | -1 | 24 |
7/6/11 18:47 | 7/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,856 | 41.76 | 33 | -92 | -5 | 1,949 | D | -9 | 20 | 14 | -3 | 3 | 5 | 4 | 0 | 1 | -2 | -6 | -11 | -1 | 24 |
6/3/11 19:34 | 6/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,948 | D | -7 | 15 | 11 | 4 | 2 | 0 | 2 | 1 | 0 | 0 | 2 | -3 | -3 | 18 |
6/3/11 19:34 | 6/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,831 | 41.50 | 33 | -92 | -5 | 1,948 | D | -7 | 15 | 11 | 4 | 2 | 0 | 2 | 1 | 0 | 0 | 2 | -3 | -3 | 18 |
5/3/11 19:24 | 5/2/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,948 | D | -9 | 2 | 3 | 6 | 1 | -1 | 0 | 2 | -1 | -1 | -1 | 0 | 3 | 24 |
5/3/11 19:24 | 5/2/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,697 | 40.04 | 33 | -92 | -5 | 1,948 | D | -9 | 2 | 3 | 6 | 1 | -1 | 0 | 2 | -1 | -1 | -1 | 0 | 3 | 24 |
4/5/11 21:15 | 4/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 759 | 8.22 | 33 | 92 | 5 | 1,948 | D | -9 | -6 | 21 | 17 | 11 | 8 | 2 | 1 | 0 | -1 | -1 | -1 | -9 | 15 |
4/5/11 21:15 | 4/1/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,923 | 42.50 | 33 | -92 | -5 | 1,948 | D | -9 | -6 | 21 | 17 | 11 | 8 | 2 | 1 | 0 | -1 | -1 | -1 | -9 | 15 |
3/7/11 20:01 | 3/3/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.dm | 2,276 | 8.22 | 33 | 277 | 17 | 1,913 | D | -7 | -14 | 23 | 8 | 7 | 6 | 7 | 6 | 0 | -1 | 4 | 0 | -4 | 13 |
3/7/11 20:01 | 3/3/11 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.dm | -11,100 | 40.08 | 33 | -277 | -13 | 1,913 | D | -7 | -14 | 23 | 8 | 7 | 6 | 7 | 6 | 0 | -1 | 4 | 0 | -4 | 13 |
10/26/10 20:14 | 10/22/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 522 | 3.70 | 33 | 141 | 8 | 1,913 | D | -13 | -10 | -2 | 18 | 15 | 10 | 7 | 3 | 0 | 2 | -7 | -4 | 0 | 6 |
8/23/10 18:21 | 8/19/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 462 | 3.70 | 33 | 125 | 8 | 1,772 | D | -40 | -29 | -32 | -11 | -5 | -5 | -6 | -4 | -2 | -1 | 9 | 16 | 20 | 13 |
8/10/10 19:35 | 8/9/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 100 | 8.22 | 33 | 12 | 1 | 1,647 | D | -35 | -22 | -22 | -7 | 0 | 8 | 7 | 2 | -3 | -5 | -5 | 9 | 7 | 3 |
7/15/10 18:32 | 7/13/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 370 | 3.70 | 33 | 100 | 7 | 1,634 | D | -35 | -22 | -23 | -24 | -3 | -4 | 0 | 0 | -8 | -6 | -1 | 3 | 7 | 19 |
7/15/10 18:32 | 7/13/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,515 | 35.15 | 33 | -100 | -6 | 1,634 | D | -35 | -22 | -23 | -24 | -3 | -4 | 0 | 0 | -8 | -6 | -1 | 3 | 7 | 19 |
6/10/10 12:14 | 6/8/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 370 | 3.70 | 33 | 100 | 7 | 1,634 | D | -39 | -26 | -29 | -30 | -19 | -16 | -8 | -5 | 2 | 9 | 6 | 3 | 13 | 25 |
6/10/10 12:14 | 6/8/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,371 | 33.71 | 33 | -100 | -6 | 1,634 | D | -39 | -26 | -29 | -30 | -19 | -16 | -8 | -5 | 2 | 9 | 6 | 3 | 13 | 25 |
5/13/10 18:25 | 5/11/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | M.d | 370 | 3.70 | 33 | 100 | 7 | 1,634 | D | -26 | -10 | -14 | -13 | -12 | -1 | 1 | 5 | -4 | -1 | -12 | -12 | -2 | 3 |
5/13/10 18:25 | 5/11/10 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Martin John C | CA | DO | CB,CEO | S.d | -3,961 | 39.61 | 33 | -100 | -6 | 1,634 | D | -26 | -10 | -14 | -13 | -12 | -1 | 1 | 5 | -4 | -1 | -12 | -12 | -2 | 3 |